T1	Participants 158 207	first-line treatment of metastatic breast cancer.
T2	Participants 434 499	first-line treatment of women with metastatic breast cancer (MBC)
T3	Participants 522 572	Women (n=509) with MBC and normal cardiac function
T4	Participants 1620 1646	first-line therapy for MBC
